Abstract
During continuous proliferation, cyclin D1 protein is induced to high levels in a Ras-dependent manner as cells progress from S phase to G2 phase. To understand the mechanism of the Ras-dependent cyclin D1 induction, cyclin D1 mRNA levels were determined by quantitative image analysis following fluorescent in situ hybridization. Although a slight increase in mRNA expression levels was detected during the S/G2 transition, this increase could not explain the more robust induction of cyclin D1 protein levels. This suggested the involvement of post-transcriptional regulation as a mechanism of cyclin D1 protein induction. To directly test this hypothesis, the cyclin D1 transcription rate was determined by run-on assays. The transcription rate of cyclin D1 stayed steady during the synchronous transition from S the G2 phase. We further demonstrated that cyclin D1 protein levels could increase during G2 phase in the absence of new mRNA synthesis. α-Amanitin, a transcription inhibitor, did not suppress cyclin D1 protein elevation as the cells progressed from S to G2 phase, even though the inhibitor was able to completely block cyclin D1 protein induction during reentry into the cell cycle from quiescence. The half life of cyclin D1 protein was shortest during S phase indicating that a change in protein stability might play a role in post-translational induction of cyclin D1 in G2 phase. These data indicate a fundamental difference in the regulation of cyclin D1 production during continuous cell cycle progression and re-initiation of the cell cycle.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Adolph S, Brusselback S, Muller R . 1993 J. Cell Biol. Sci. 105: 113–122
Agami R, Bernards R . 2000 Cell 102: 55–66
Albanese C, Johnson J, Watanabe G, Eklund N, Vu D, Arnold A, Pestell RG . 1995 J. Biol. Chem. 270: 23589–23597
Alt JR, Cleveland JL, Hannink M, Diehl JA . 2000 Genes Dev. 14: 3102–3114
Amanatullah DF, Zafonte BT, Albanese C, Fu M, Messiers C, Hassell J, Pestell RG . 2001 Methods Enzymol. 333: 116–127
Baldin V, Lukas J, Marcote MJ, Pagano M, Draetta G . 1993 Genes Dev. 7: 812–821
Brewer JW, Diehl JA . 2000 Proc. Natl. Acad. Sci. USA 97: 12625–12630
Brown EJ, Schreiber SL . 1996 Cell 86: 517–520
DeGregori J, Kowalik T, Nevins JR . 1995 Mol. Cell. Biol. 15: 4215–4224
DeLisle AJ, Graves RA, Marzluff WF, Johnson LF . 1983 Mol. Cell. Biol. 3: 1920–1929
Diehl JA, Cheng M, Roussel FM, Sherr CJ . 1998 Genes Dev. 12: 3499–3511
Dirks RW . 1996 Histochem. Cell Biol. 106: 151–166
Dirks RW, Raap AK . 1995 Histochem. Cell Biol. 104: 391–395
Dufourny B, van Teeffelen HA, Hamelers IH, Sussenbach JS, Steenbergh PH . 2000 J. Endocrinol. 166: 329–338
Evan GI, Vousden KH . 2001 Nature 411: 342–348
Germain D, Russell A, Thompson A, Hendley J . 2000 J. Biol. Chem. 275: 12074–12079
Gille H, Downward J . 1999 J. Biol. Chem. 274: 22033–22040
Gingras AC, Raught B, Sonenberg N . 2001 Genes Dev. 15: 807–826
Hann SR, Thompson CB, Eisenman RN . 1985 Nature 314: 366–369
Hashemolhosseini S, Nagamine Y, Morley SJ, Desrivieres S, Mercep L, Ferrari S . 1998 J. Biol. Chem. 273: 14424–14429
Hitomi M, Stacey DW . 1999a Mol. Cell. Biol. 19: 4623–4632
Hitomi M, Stacey DW . 1999b Curr. Biol. 9: 1075–1084
Hitomi M, Stacey DW . 2001 FEBS Lett. 490: 123–131
Jefferies HB, Fumagalli S, Dennis PB, Reinhard C, Pearson RB, Thomas G . 1997 EMBO J. 16: 3693–3704
Kotelnikov V, Cass L, Coon JS, Spaulding D, Preisler HD . 1997 Clin. Cancer Res. 3: 669–673
Kovary K, Bravo R . 1992 Mol. Cell. Biol. 12: 5015–5023
Lin S, Wang W, Wilson GM, Yang X, Brewer G, Holbrook NJ, Gorospe M . 2000 Mol. Cell. Biol. 20: 7903–7913
Lukas J, Jadayel D, Bartkova J, Nacheva E, Dyer MJS, Strauss M, Bartek J . 1994a Oncogene 9: 2159–2167
Lukas J, Pagano M, Staskova Z, Draetta G, Bartek J . 1994b Oncogene 9: 707–718
Mettouchi A, Klein S, Guo W, Lopez-Lago M, Lemichez E, Westwick JK, Giancotti FG . 2001 Mol. Cell 8: 115–127
Muise-Helmericks RC, Grimes HL, Bellacosa A, Malstrom SE, Tsichlis PN, Rosen N . 1998 J. Biol. Chem. 273: 29864–29872
Mulcahy LS, Smith MR, Stacey DW . 1985 Nature 313: 241–243
Pacold ME, Suire S, Perisic O, Lara-Gonzalez S, Davis CT, Walker EH, Hawkins PT, Stephens L, Eccleston JF, Williams RL . 2000 Cell 103: 931–943
Palakurthi SS, Fluckiger R, Aktas H, Changolkar AK, Shahsafaei A, Harneit S, Kilic E, Halperin JA . 2000 Cancer Res. 60: 2919–2925
Pardee AB . 1989 Science 246: 603–608
Pervin S, Singh R, Chaudhuri G . 2001 Proc. Natl. Acad. Sci. USA 98: 3583–3588
Raap AK, van de Rijke FM, Dirks RW . 1997 Methods Mol. Biol. 75: 367–375
Ramljak D, Calvert RJ, Wiesenfeld PW, Diwan BA, Catipovic B, Marasas WFO, Victor TC, Anderson LM, Gelderblom WCA . 2000 Carcinogenesis 21: 1537–1546
Rickles R, Marashi F, Sierra F, Clark S, Wells J, Stein J, Stein G . 1982 Proc. Natl. Acad. Sci. USA 79: 749–753
Rinker-Schaeffer C, Austin V, Zimmer S, Rhoads RE . 1992 J. Biol. Chem. 267: 10659–10664
Rodriguez-Viciana P, Warne PH, Dhand R, Vanhaesebroeck B, Gout I, Fry MJ, Waterfield MD, Downward J . 1994 Nature 370: 527–534
Rosenwald IB, Kaspar R, Rousseau D, Gehrke L, Leboulch P, Chen JJ, Schmidt EV, Sonenberg N, London IM . 1995 J. Biol. Chem. 270: 21176–21180
Rosenwald IB, Lazaris KA, Sonenberg N, Schmidt EV . 1993 Mol. Cell. Biol. 13: 7358–7363
Rousseau D, Kaspar R, Rosenwald I, Gehrke L, Sonenberg N . 1996 Proc. Natl. Acad. Sci. USA 93: 1065–1070
Sa G, Hitomi M, Harwalker J, Stacey A, Chen G, Stacey DW . 2002 Cell Cycle 1: 50–58
Sherr CJ . 1995 Trends Biochem. Sci. 20: 187–190
Sherr CJ, Matsushime H, Roussel MF . 1992 Ciba Found. Symp. 170: 209–219
Shu J, Hitomi M, Stacey DW . 1996 Oncogene 13: 2421–2430
Sicinski P, Donaher JL, Parker SB, Li T, Fazeli A, Gardner H, Haslam SZ, Bronson RT, Elledge SJ, Weinberg RA . 1995 Cell 82: 621–630
Smith R, Peters G, Dickson C . 1995 Genomics 25: 85–92
Srivastava RAK, Schonfeld G . 1994 Methods Mol. Biol. 31: 281–288
Stacey DE, Chen G, Hitomi M . 2000 Mol. Cell. Biol. 20: 9127–9137
Stacey DW, Hitomi M, Kanovsky M, Gan L, Johnson EM . 1999 Oncogene 18: 4254–4261
Thompson CB, Challoner PB, Neiman PE, Groundine M . 1985 Nature 314: 363–366
Vogelstein B, Lane D, Levine AJ . 2000 Nature 408: 307–310
Wei X, Somanathan S, Samarabandu J, Berezney R . 1999 J. Cell Biol. 146: 543–558
Yan Z, DeGregori J, Shohet R, Leone G, Stiliman B, Nevins JR, Williams RS . 1998 Proc. Natl. Acad. Sci. USA 95: 3603–3608
Acknowledgements
We thank Clive Dickson for providing us a mouse cyclin D1 genomic clone. We are also grateful for Akiko Nishiyama for technical advice, Jyoti Harwalker, Jeff Nye and Brandon Abood for helping in image analysis, and William C Stacey for reviewing the manuscript. This work was supported by NIH Grants GM52271 and CA92194.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Guo, Y., Stacey, D. & Hitomi, M. Post-transcriptional regulation of cyclin D1 expression during G2 phase. Oncogene 21, 7545–7556 (2002). https://doi.org/10.1038/sj.onc.1205907
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1205907
Keywords
This article is cited by
-
Stochastic modeling suggests that noise reduces differentiation efficiency by inducing a heterogeneous drug response in glioma differentiation therapy
BMC Systems Biology (2016)
-
PTH-Induced Osteoblast Proliferation Requires Upregulation of the Ubiquitin-Specific Peptidase 2 (Usp2) Expression
Calcified Tissue International (2016)
-
Oncolytic adenovirus-mediated short hairpin RNA targeting MYCN gene induces apoptosis by upregulating RKIP in neuroblastoma
Tumor Biology (2015)
-
Arsenic trioxide suppressed mantle cell lymphoma by downregulation of cyclin D1
Annals of Hematology (2014)
-
PDGF-induced airway smooth muscle proliferation is associated with Human antigen R activation and could be weakened by AMPK activation
Molecular Biology Reports (2012)